Skip to main content

Table 1 Demographic Characteristics

From: Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial

 Placebo500 mg
2-HOBA acetate
750 mg
2-HOBA acetate
Total
Volunteers (n)66618
Sex: female [n (%)]4 (67)3 (50)4 (67)11 (61)
Age (y)33.5 ± 13.635.2 ± 13.830.8 ± 11.933.2 ± 12.5
Height (cm)167.6 ± 11.0175.3 ± 11.6169.3 ± 9.0170.8 ± 10.6
Weight (kg)64.2 ± 10.376.3 ± 9.770.7 ± 9.470.4 ± 10.6
BMI (kg/m2)22.8 ± 1.824.8 ± 2.524.6 ± 2.224.0 ± 2.3
Race [n (%)]
 Black/African American1 (17)2 (33)0 (0)3 (17)
 White5 (83)4 (67)6 (100)15 (83)
Ethnicity [n (%)]
 Hispanic/Latino1 (17)1 (17)0 (0)2 (11)
 Not Hispanic/Latino4 (80)5 (83)6 (100)15 (88)
 Not Reported1 (17)0 (0)0 (0)1 (6)
  1. Data are presented as means ± SD unless otherwise noted